Rosuvastatin: A Review of its Use in the Prevention of Cardiovascular Disease in Apparently Healthy Women or Men with Normal LDL-C Levels and Elevated hsCRP Levels

Author： Carter Natalie J.  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.10, Iss.6, 2010-12, pp. : 383-400

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Telmisartan: A Review of its Use in Cardiovascular Disease Prevention

By Frampton James E.  

Drugs, Vol. 71, Iss. 6, 2011-04 ,pp. : 651-677

Adis International

Access to resources Recommend Favorite

Reduction of Serum LDL-C Levels: A Relationship to Clinical Benefits

By LaRosa J.C.  

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 4, 2003-01 ,pp. : 271-281

Adis International

Access to resources Recommend Favorite

Switch to rosuvastatin leads to greater LDL-C reduction

By  

Inpharma, Vol. 1, Iss. 1436, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Peginterferon -2a (40KD) Plus Ribavirin: A Review of its Use in the Management of Patients with Chronic Hepatitis C and Persistently ‘Normal’ ALT Levels

By Gillian M. Keating   Greg L. Plosker  

Drugs, Vol. 65, Iss. 4, 2005-01 ,pp. : 521-536

Adis International

Access to resources Recommend Favorite

Identifying and Attaining LDL-C Goals: Mission Accomplished? Next Target: New Therapeutic Options to Raise HDL-C Levels

By  

Current Drug Targets, Vol. 8, Iss. 3, 2007-01 ,pp. : 483-488

Bentham Science Publishers

Access to resources Recommend Favorite